NASDAQ$AKYA
Akoya Biosciences Inc · Q4 2021 earnings
Q4 2021 earnings · · Investor relations
Briefing
Akoya reported a record quarterly revenue and grew its installed base.
Akoya Biosciences reported a strong finish to 2021 with record quarterly revenue of $16.2 million, representing a 26% increase compared to the prior year period. The company's installed base grew to nearly 700 instruments worldwide, and there are approximately 500 publications on Akoya platforms to date. The commercial launch of the PhenoCycler™-Fusion System was a highlight of the quarter.
- Total revenue was $16.2 million, a 26% increase compared to the prior year period.
- Product revenue was $12.9 million, a 23% increase compared to the prior year period.
- Services and other revenue totaled $3.2 million, a 33% increase compared to the prior year period.
- Gross profit was $10.2 million, a 29% increase compared to the prior year period, with a gross profit margin of 63.3%.
Headline financials
Revenue & EPS history
Akoya · Revenue · Quarterly
$16.2M
Revenue by segment
Akoya · $16.2M total across 2 segments · Q4 2021
- Product revenue$12.9M+23.4%80.0%
- Service and other revenue$3.24M+32.8%20.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 10 quarterly earnings reports
-3.7%
Avg return
Earnings day
-8.6%
Avg return
5 days after
-17.2%
Avg return
30 days after
53%
10 / 19 earnings
Positive
+13.7%
Q4 2021
Best reaction
-31.9%
Q1 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | — | — | — | |
| Q1 2025 | +1.0% | +24.8% | +23.8% | |
| Q4 2025 | +3.8% | +9.2% | -30.7% | |
| Q3 2024 | -24.9% | -33.2% | -29.5% | |
| Q2 2024 | -9.5% | -0.9% | +5.5% | |
| Q1 2024 | -31.9% | -35.1% | -50.0% | |
| Q4 2023 | -15.4% | -17.1% | -28.1% | |
| Q3 2023 | +10.0% | +6.9% | +16.4% | |
| Q2 2023 | +0.9% | -6.5% | -23.9% | |
| Q1 2023 | -2.5% | -17.1% | -18.8% | |
| Q4 2022 | -7.3% | -17.2% | -36.6% | |
| Q3 2022 | -15.1% | — | — | |
| Q2 2022 | +5.0% | — | — | |
| Q1 2022 | -11.9% | — | — | |
| Q4 2021 | +13.7% | — | — | |
| Q3 2020 | +1.5% | — | — | |
| Q3 2021 | +0.2% | — | — | |
| Q2 2021 | -0.1% | — | — | |
| Q4 2020 | +9.5% | — | — | |
| Q1 2021 | +2.3% | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro